RTHM

RTHM is a secure health platform that makes it easy to gather your records, connect the dots with AI, and affordably access treatments.

12/18/2025

The RTHM team had an inspiring time at Mayo Clinic’s VIBE Summit, where innovators, clinicians, and researchers gathered to explore how innovation, AI, and intelligent automation can transform patient care.

At the summit, co-founders Dr. Jennifer Curtin and Dr. Ryan Kellogg met with key people across the ecosystem offering a demo of RTHM’s tools to support bringing personalized and effective care to patients with infection-associated chronic conditions at scale. As a participating company in the Mayo Clinic Platform_Accelerate program, RTHM is already working with Mayo’s large, de-identified clinical dataset to see if they can predict the most effective next tests and treatments for people with IACCs — helping get people to the right diagnosis and treatments, faster.

12/16/2025

Not all research is created equal.

In this clip, Dr. Jennifer Curtin, RTHM Co-founder and Chief Medical Officer, explains why AI must be built on the right evidence to truly support people living with complex chronic illness.

Several clinical AI tools still surface outdated or incorrect guidance for ME/CFS. RTHM’s intelligence platform is different. The platform prioritizes carefully curated research that reflects current guidance and excludes notoriously flawed research (i.e. around GET and CBT for ME/CFS) in the IACC space.

RTHM’s HIPAA-compliant intelligence platform securely brings all your health data into one place and uses research-supported, IACC-informed AI to surface patterns, explain findings, and support you in identifying your next steps. For many people, this is the first time their case feels clearly organized in one place, actionable, and truly understood.

Learn more at rthm.com.

12/10/2025

A major new RECOVER Initiative study analyzing 6.4 million electronic health records from 2020–2024 reveals a critical pattern: the risk of Long COVID has remained stable across the entire pandemic.

Using multiple definitions of Long COVID, researchers found consistent incidence rates in both adults and children, with no meaningful decline even through three Omicron waves. Peaks aligned with new variants, but overall risk did not fall, indicating that Long COVID continues to pose a persistent public health challenge.

The findings reinforce that Long COVID is not diminishing over time and require continued and renewed attention, prevention, and support for those affected.

Stay informed on the latest IACC research and sign up for our email list through the link in our bio.

👉 Read the full study: https://doi.org/10.1093/cid/ciaf046

12/05/2025

People living with Long Covid and other IACCs need clarity and support.

Maya, a nurse who has been bedridden for four years, shares how RTHM’s intelligence platform helped her understand complex imaging results, identify next steps, and see her full health picture without spending weeks gathering information on her own.

RTHM’s HIPAA-compliant intelligence platform securely brings all your health data into one place and uses research-grounded, IACC-informed AI to surface patterns, explain findings, and support decision-making. For many patients, this is the first time their case feels clearly organized in one place, actionable, and truly understood.

It’s not just AI. It’s AI designed for people living with ME/CFS, Long COVID, POTS, MCAS, EDS, and other IACCs.

Learn more about RTHM’s intelligence platform here: rthm.com

12/01/2025

Many people still don’t know that metformin, a medication used safely for decades to treat diabetes, may help lower the risk of Long COVID when taken early during acute COVID.

In a recent article, “Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?” by The Sick Times, Dr. Jennifer Curtin explained why she uses metformin during acute COVID for her Long COVID patients.

“We generally use metformin during acute COVID reinfections for patients, just to try and reduce any potential worsening.”

The COVID-OUT phase 3 trial found that people treated with metformin during an active SARS-CoV-2 infection were ~41% less likely to develop Long COVID vs. placebo.

Read the full story at The Sick Times: https://ow.ly/iTrC50XAl5C

11/25/2025

A recent study shows that an AI tool called BioMapAI can identify people with ME/CFS with 90% accuracy by analyzing stool, blood, and other routine lab data.

Developed by researchers at the Jackson Laboratory and Duke University School of Medicine, BioMapAI integrated multi-omics data from 153 ME/CFS patients and 96 controls, revealing how disruptions across the microbiome, immune system, and metabolism are linked to fatigue, pain, sleep, and emotional symptoms.

The study underscores that ME/CFS may not have a single biomarker but rather a network of systems out of balance, requiring multiple interventions to restore health.

Stay informed on the latest IACC research and sign up for our email list through the link in our bio.

👉 Learn how AI is helping map complex disease biology. Read the full study: https://doi.org/10.1038/s41591-025-03788-3

11/24/2025

Not all AI is secure enough for your health data.

Dr. Jennifer Curtin, RTHM’s Co-Founder and Chief Medical Officer, explains how the RTHM platform was designed specifically for people living with infection associated chronic conditions (IACCs), where privacy, grounding in relevant research, and clinical context matter.

The system can securely process hundreds of pages of medical records to identify patterns, summarize findings, and generate meaningful insights about your case.
It’s not just AI. It’s AI designed for people living with ME/CFS, Long COVID, POTS, MCAS, and other IACCs.

Explore the platform today and see how it can support you on your own health journey. 👉https://www.rthm.com/

11/17/2025

People living with Long COVID, ME/CFS, POTS, and other infection associated chronic conditions are finding new clarity and confidence with RTHM’s compliant intelligence platform.

It helps you bring together all your health data in one secure place, allowing you to gain a better understanding of your health history and explore treatment, lifestyle, and testing options based on the latest research and clinical guidelines.

The HIPAA-compliant AI chat is informed by your data and can help you explore, trend, and understand your lab results, brainstorm treatments, understand key research, prepare for clinician visits, draft support letters, and so much more. Each person’s story shows what’s possible when you can finally see your full health picture and explore next steps with confidence.

Learn more about how RTHM’s intelligence platform is changing what’s possible for people with IACCs.

https://www.rthm.com/

11/13/2025

In this clip, Dr. Jennifer Curtin, RTHM’s Co-Founder and Chief Medical Officer, shares how the new RTHM platform empowers people living with infection associated chronic conditions to take control of their health journey.

It brings all your medical records into one secure place, generates a personalized Health Roadmap grounded in curated research, summarizes your health history, comes up with questions to ask your clinician, shows you how others responded to treatments, and more.

The platform is HIPAA compliant and securely encrypted.

Try the RTHM platform today and start uncovering insights into your own case. 🔗: https://rthm.com/

11/12/2025

A new study finds that children face twice the risk of developing Long COVID after a second SARS-CoV2 infection.

Data from over 465,000 patients under 21 years old showed that reinfection during the Omicron era was linked to a higher rate of Long COVID diagnoses, regardless of vaccination status or acute illness severity.

Researchers note the risk may be cumulative with each infection, highlighting the importance of prevention and continued public health awareness for children and families.

👉 Stay informed on the latest COVID-19 and Long COVID research and sign up for our email list through the link in our bio.

Full study: 10.1016/S1473-3099(25)00476-1

11/06/2025

When every symptom leads to new questions and confusion, finding clarity can feel impossible.

Karl shares how the RTHM platform has helped him make sense of the uncertainty that comes with Long COVID, ME/CFS, POTS, and MCAS.

After months of searching for answers and managing a wide range of symptoms, he’s used the platform to organize his medical information, explore evidence-supported options, and track what’s working for him—all in one secure, supportive place.

For people like Karl, RTHM’s platform offers clarity, insight, and a path forward.

Try the RTHM platform today and see how it can empower you on your own health journey.

https://www.rthm.com/

11/04/2025

AI is powerful when it’s built with your privacy in mind. RTHM’s new intelligence platform keeps your data encrypted and HIPAA compliant, made for patients, not ad networks or AI models. Eliana highlights what matters most in keeping patient data safe.

Address

2261 Market Street #10535
San Francisco, CA
94114

Website

https://www.rthm.com/, https://linktr.ee/rthm_health, https://www.direct.rthm.com/intelligence?utm_source=fb&utm_medium=

Alerts

Be the first to know and let us send you an email when RTHM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RTHM:

Shortcuts

Want your practice to be the top-listed Clinic in San Francisco?